These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 27264337)

  • 1. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
    Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
    Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
    Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
    Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
    Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease.
    Chen JJ; Yang G; Yan QQ; Zhao J; Li S
    Rev Neurosci; 2019 Dec; 31(1):77-87. PubMed ID: 31318699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
    Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
    OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
    J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
    Kiko T; Nakagawa K; Tsuduki T; Furukawa K; Arai H; Miyazawa T
    J Alzheimers Dis; 2014; 39(2):253-9. PubMed ID: 24157723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
    PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.
    Frørup C; Mirza AH; Yarani R; Nielsen LB; Mathiesen ER; Damm P; Svare J; Engelbrekt C; Størling J; Johannesen J; Mortensen HB; Pociot F; Kaur S
    Front Immunol; 2021; 12():744509. PubMed ID: 34691048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
    Kumar S; Vijayan M; Reddy PH
    Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
    World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
    Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
    J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
    Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
    Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.